Personalized Medicine is often defined as “the right treatment for the right person at the right time.” Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming To Read The Complete Report Kindly Visit: http://www.marketresearchreports.biz/analysis/170291 For All Latest Reports Kindly visit: http://www.marketresearchreports.biz

1. Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric
Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) Market & Forecast
Personalized Medicine is often defined as “the right treatment for the right person at the right
time.” Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly
becoming the reality of future in the diagnostics industry
By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit
CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by
technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care
Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.
By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion
by 2018. Diabetes management test and Cancer management test are the leading market in this segment.
Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry, Sepsis
Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other
Testing)” report provides a comprehensive analysis of the emerging personalized medicine diagnostic
market segments, including their dynamics, size, market share, key investors, clinical trials statement,
technological trends, company analysis and a realistic future potential for personalized medicine in clinical
testing. The report also entails major drivers and challenges of personalized medicine diagnostic market. This
173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market.
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric
Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) contains 12 chapters
Chapter 1 is Executive Summary Chapter 2 contains worldwide personalized medicine diagnostic market &
forecast (2011 – 2018). The market includes technological & disease-wise personalized medicine
diagnostics market Chapter 3 contains worldwide personalized medicine diagnostic market share segment.
Segment include Technology, Disease-Wise Chapter 4 contains segment-wise technological personalized
diagnostic market & forecast (2010 - 2018) Chapter 5 contains geographical segment-wise personalized
diagnostic market & forecast (2011 - 2018) Chapter 6 contains disease-wise personalized diagnostic market
share & forecast (2011 - 2018) Chapter 7 contains disease-wise personalized diagnostic market & forecast
(2011 - 2018) Chapter 8 and 9 contains clinical trial statement and key investors in Personalized Diagnostics
Medicine Market Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine Chapter
12 contains company analysis of Personalized Medicine
Companies analyzed in this report are:
HistoRx A&G Pharmaceuticals Inc 20/20 GeneSystems Tethys Bioscience Genomas Inc
table Of Content
1. Executive Summary
2. Worldwide Personalized Medicine Diagnostic Market & Forecast
2.1 By Technology – Worldwide Personalized Medicine Diagnostic Market & Forecast
2.2 By Diseases – Worldwide Personalized Medicine Diagnostic Market & Forecast
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecu

2. 3. Worldwide – Personalized Medicine Diagnostic Market Share Segment
3.1 By Technology – Worldwide Personalized Medicine Diagnostic Market Share & Forecast
3.2 By Disease – Worldwide Personalized Medicine Diagnostic Market Share & Forecast
4. By Technology – Personalized Medicine Diagnostic Market & Forecast
4.1 Worldwide – Pharmacogenetics Market & Forecast
4.2 Worldwide – Pharmacogenomics Market & Forecast
4.3 Worldwide – Snp Genotyping Market & Forecast
4.4 Worldwide – Pharmacoproteomics Market & Forecast
4.5 Worldwide – Biochips Market & Forecast
4.6 Worldwide – Point Of Care Test Market & Forecast
4.7 Worldwide – Molecular Diagnostics Market & Forecast
4.8 Worldwide – Genetic Screening Market & Forecast
5. By Geographical Segmentation – Personalized Medicine Diagnostic Market & Forecast
5.1 North America – Personalized Medicine Diagnostic Market & Forecast
5.2 Western Europe (eu5) – Personalized Medicine Diagnostic Market & Forecast
6. By Disease – Personalized Medicine Diagnostic Market Share & Forecast
6.1 Worldwide – Cardiovascular Management Test Market Share & Forecast
6.2 Worldwide – Diabetes Management Test Market Share & Forecast
6.3 Worldwide – Coagulation Test Market Share & Forecast
6.4 Worldwide – Cancer Management Test Market Share & Forecast
6.5 Worldwide – Infectious Diseases Test Market Share & Forecast
7. By Disease – Personalized Medicine Diagnostic Market & Forecast
7.1 Worldwide – Cardiovascular Management Test Market & Forecast
7.2 Worldwide – Cardiovascular Management Test Market & Forecast (by Segment)
7.2.1 Cardiac Marker Immunoassays Market & Forecast
7.2.2 Cardiac Risk Markers Market & Forecast
7.2.3 Cardiac Markers Molecular Test Market & Forecast
7.3 Worldwide – Diabetes Management Test Market & Forecast
7.4 Worldwide – Diabetes Management Test Market & Forecast (by Segment)
7.4.1 Blood Glucose Monitoring Market & Forecast
7.4.2 Hemoglobin A1c (hba1c) Test Market & Forecast
7.5 Worldwide – Coagulation Test Market & Forecast
7.6 Worldwide – Coagulation Test Market & Forecast (by Segment)
7.6.1 Routine Coagulation Test Market & Forecast
7.6.2 Molecular Coagulation Test Market & Forecast
7.7 Worldwide – Cancer Management Test Market & Forecast
7.8 Worldwide – Cancer Management Test Market & Forecast (by Segment)
7.8.1 Pharmacodiagnostic Histology Test Market & Forecast
7.8.2 Flow Cytometry Market & Forecast
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecu

3. 7.8.3 Tumor Markers Market & Forecast
7.8.4 Human Papillomavirus (hpv) Test Market & Forecast
7.8.5 Molecular Assays Market & Forecast
7.8.6 Circulating Tumor Cells Market & Forecast
7.9 Worldwide – Infectious Diseases Test Market & Forecast
7.10 Worldwide – Infectious Diseases Test Market (by Segment)
7.10.1 Human Immunodeficiency Virus (hiv) Cd4 Count Market & Forecast
7.10.2 Human Immunodeficiency Virus (hiv) Viral Load Test Market & Forecast
7.10.3 Hepatitis C (hcv) Viral Load Test Market & Forecast
7.10.4 Hepatitis B (hbv) Viral Load Test Market & Forecast
7.10.5 Hospital Acquired Infections (hai) Molecular Test Market & Forecast
7.10.6 Sepsis Immunos Test Market & Forecast
7.10.7 Multi Drug Resistant Tuberculosis (mdr-tb) Test Market & Forecast
7.11 Worldwide – Microbiology Identification/ Antibiotic Sensitivity Test (id/ast) Market & Forecast
7.12 Worldwide – Psychiatric Disorders Test Market & Forecast
7.13 Worldwide – Transplant Tissue Typing (hla) Test Market & Forecast
7.14 Worldwide – Molecular Blood Typing Market & Forecast
8. Personalized Medicine Clinical Trial Statement
8.1 Biomarker Research For Personalized Medicine In Blood Cancer Patient
8.2 Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards
Personalized Medicine
8.3 Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing At Therapy Initiation (warfarin)
8.4 Genetic Analysis For Personalized Medicine For Morbid Obesity
8.5 Pharmacogenomics For Antidepressant Guidance & Education
8.6 I-spy 2 Trial (investigation Of Serial Studies To Predict Your Therapeutic Response With Imaging &
Molecular Analysis)
8.7 Genetic Mechanisms In Human Hypertension Raas Inhibition Study
8.8 Open Label Study For The Functional Characterization Of Drug Metabolism And Transport
8.9 Personalized Therapy In Non-small Cell Lung Cancer
8.10 A Pilot Study Of Personalized Medicine For Pediatric Asthma
9. Key Investors In Personalized Medicine Market
10. Key Drivers (opportunities) Of Growth In Personalized Medicine Diagnostic Market
10.1 Government Agencies Shaping Personalized Medicine Diagnostic Market
10.2 Organizations Will Profit Together, Not Alone In The Personalized Medicine
10.3 The Blockbuster Model Of One Drug Fits All Is Under Pressure
11. Challenges In Personalized Medicine Diagnostic Market
11.1 Reimbursement Policy & Regulatory Framework
11.2 Regulatory Framework
11.3 Payers Worry That Cost Of Personalized Medicine Could Be Unsustainable
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecu

4. 12. Company Analysis
12.1 Historx
12.1.1 Focus/market Served
12.1.2 Outlook/ Strategy For Success
12.1.3 Products
12.2 A&g Pharmaceutical, Inc
12.2.1 Focus/market Served
12.2.2 Outlook/strategy For Success
12.2.3 Products
12.3 20/20 Genesystems
12.3.1 Focus/market Served
12.3.2 Outlook/strategy For Success
12.3.3 Products
12.4 Tethys Bioscience
12.4.1 Focus/market Served
12.4.2 Outlook/strategy For Success
12.4.3 Products
12.5 Genomas, Inc.
12.5.1 Focus/market Served
12.5.2 Products
Market Research Report(http://www.marketresearchreports.biz/) Marketresearchreports.biz is the most
comprehensive collection of market research reports. Marketresearchreports.biz services are especially
designed to save time and money of our clients. We are a one stop solution for all your research needs, our
main offerings are syndicated research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.com
Website: www.marketresearchreports.biz
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecu